While jaundice is a fairly common symptom of gallbladder cancer, persistent severe itchy skin, without known causes, too ...

Chemoradiation combined with immunotherapy significantly boosts survival in patients with resected extrahepatic ...

The 7 major gallbladder cancer markets size reached a value of US$ 51.6 Million in 2023. Looking forward, IMARC Group expects ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...

Olaparib demonstrated activity in a phase 2 trial of patients who had advanced biliary tract cancer with homologous recombination repair (HRR) mutations. Results from this trial were presented at the ...

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...

Cancer deaths linked to obesity have more than tripled in the United States since 1999, a new study finds. Researchers say the steepest increases are among women, older adults, Black people, Native ...

Efforts to train robots to perform certain kinds of surgical procedures without human help have reached a "critical milestone ...

The new study found that Midwestern states had the highest rates of obesity-linked cancer deaths, while the Northeast fared ...

Cancer deaths linked to obesity more than tripled in the United States during the past two decades, a new study says.